Join Class Action »
Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of MultiPlan Corporation (NYSE: MPLN, MPLN.WS, XXXX, CCXX.WS, CCXX.U) from July 12, 2020 through November 10, 2020 (the “Class Period”). The lawsuit seeks to recover damages for MultiPlan Corporation investors under the federal securities laws.
If you bought MultiPlan Corporation securities between July 12, 2020 through November 10, 2020, and would like to join the action, please click “Join This Class Action,” above.
SHAREHOLDER ALERT: Zhang Investor Law Announces a Securities Class Action Lawsuit Against MultiPlan Corporation – MPLN, MPLN.WS, CCXX, CCXX.WS, CCXX.U
New York, N.Y., March 4, 2021. Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of MultiPlan Corporation (NYSE; MPLN, MPLN.WS, CCXX, CCXX.WS, CCXX.U) between July 12, 2020 and November 10, 2020, inclusive (the “Class Period”).
To join the MPLN, MPLN.WS, CCXX, CCXX.WS, CCXX.U class action, go to http://zhanginvestorlaw.com/cases/multiplan-corporation/ call Sophie Zhang, Esq. toll-free at 800-991-3756 or email firstname.lastname@example.org for information on the class action.
Lead plaintiff status is not required to seek compensation. You may retain counsel of your choice. You may remain an absent class member and take no action at this time..
According to the lawsuit, throughout the Class Period (1) MultiPlan was losing tens of millions of dollars in sales and revenues to Naviguard, a competitor created by one of MultiPlan’s largest customers, UnitedHealthcare, which threatened up to 35% of the Company’s sales and 80% of its levered cash flows by 2022; (2) sales and revenue declines in the quarters leading up to the Merger were not due to “idiosyncratic” customer behaviors as represented, but rather due to a fundamental deterioration in demand for MultiPlan’s services and increased competition, as payors developed competing services and sought alternatives to eliminating excessive healthcare costs; (3) MultiPlan was facing significant pricing pressures for its services and had been forced to materially reduce its take rate in the lead up to the Merger by insurers, who had expressed dissatisfaction with the price and quality of MultiPlan’s services and balanced billing practices, causing the Company’s to cut its take rate by up to half in some cases; (4) as a result of the foregoing, MultiPlan was set to continue to suffer from revenues and earnings declines, increased competition and deteriorating pricing dynamics following the Merger; (5) as a result of the foregoing, MultiPlan was forced to seek continued revenue growth and to improve its competitive positioning through pricey acquisitions, including through the purchase of HST for $140 million at a premium price from a former MultiPlan executive only one month after the Merger; and (6) as a result of the foregoing, Churchill III investors had grossly overpaid for the acquisition of MultiPlan in the Merger, and MultiPlan’s business was worth far less than represented to investors. According to the suit, these true details were disclosed by a market research firm.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 26, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://zhanginvestorlaw.com/cases/multiplan-corporation/ or to discuss your rights or interests regarding this class action, please contact Sophie Zhang, Esq. of Zhang Investor Law toll free at 800-991-3756 or via e-mail at email@example.com.
Zhang Investor Law represents investors worldwide.